Cresco Labs (CRLBF) Change in Receivables (2020 - 2026)
Cresco Labs (CRLBF) posted Change in Receivables of -$406000.0 for Q1 2026, up 98.06% on a QoQ basis from -$20.9 million in Q4 2025, and down 105.96% year-over-year from $6.8 million in Q1 2025.
Cresco Labs (CRLBF) Change in Receivables (2020 - 2026) Analysis & Trends
Cresco Labs' Change in Receivables history runs 7 years deep, the most recent figure standing at -$406000.0 for Q1 2026.
- Quarterly Change in Receivables fell 105.96% year-over-year to -$406000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$19.2 million (down 392.58% YoY) and the FY2025 annual result came in at -$12.0 million, down 795.32% from the prior year.
- Change in Receivables was -$406000.0 for Q1 2026 at Cresco Labs, up from -$20.9 million in the prior quarter.
- Across five years, Change in Receivables topped out at $14.2 million in Q4 2023 and bottomed at -$20.9 million in Q4 2025.
- A 5-year average of -$1.2 million and a median of -$1.4 million in 2024 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2023 — Change in Receivables soared 380.0% — and 2025, when it sank 472.32%.
- Cresco Labs' Change in Receivables stood at -$5.1 million in 2022, then surged by 380.0% to $14.2 million in 2023, then sank by 60.45% to $5.6 million in 2024, then sank by 472.32% to -$20.9 million in 2025, then jumped by 98.06% to -$406000.0 in 2026.
- Business Quant data shows CRLBF's Change in Receivables at -$406000.0 in Q1 2026, -$20.9 million in Q4 2025, and -$3.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -78.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 106.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -621.82 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -38.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 126.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 81.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Cresco Labs | 254.96 Mn | 99.57 Mn | 75.45 Mn | -406,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -406,000.00 |
| Mar 31, 2026 | -406,000.00 |
| Dec 31, 2025 | -20.90 Mn |
| Dec 31, 2025 | -20.90 Mn |
| Sep 30, 2025 | -3.67 Mn |
| Sep 30, 2025 | -3.67 Mn |
| Jun 30, 2025 | 5.73 Mn |
| Jun 30, 2025 | 5.73 Mn |
| Mar 31, 2025 | 6.81 Mn |
| Mar 31, 2025 | 6.81 Mn |
| Dec 31, 2024 | 5.61 Mn |
| Dec 31, 2024 | 5.61 Mn |
| Sep 30, 2024 | -1.41 Mn |
| Sep 30, 2024 | -1.41 Mn |
| Jun 30, 2024 | -4.43 Mn |
| Jun 30, 2024 | -4.43 Mn |
| Mar 31, 2024 | 1.96 Mn |
| Mar 31, 2024 | 1.96 Mn |
| Dec 31, 2023 | 14.20 Mn |
| Dec 31, 2023 | 14.20 Mn |